Pharmacovigilance Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1067381
  • December 2021
  • Pharmaceuticals
  • 214 Pages
Report Description

This report is a comprehensive study that examines the Pharmacovigilance industry in depth. With reference to key regions and major nations, the study specifies the product type of Pharmacovigilance as well as its use in various industrial verticals. Furthermore, the report identified and analysed all of the top companies functioning in the global Pharmacovigilance market arena, comparing and contrasting them based on market revenue, yearly sales volume, historical growth rate, and company strategies. The worldwide Pharmacovigilance market research offers a business strategy for current market participants to strengthen their market positions based on all of these findings. Furthermore, the paper recommends a market entry strategy for newcomers to the sector.

The top vendors and distributors operating in all of the major regions have also been highlighted in the Pharmacovigilance market report. This data and research should aid market players in strengthening their market distribution networks and expanding their geographic reach.
 
Pharmacovigilance Market Strategic Analysis 

The market was studied using several marketing methodologies such as Porter's Five Forces Analysis, player positioning analysis, SWOT analysis, market share analysis, and value chain analysis in the Pharmacovigilance market study. The market dynamics and factors such as the threat of a Pharmacovigilance substitute, the threat of new entrants into the Pharmacovigilance market, buyer bargaining power, supplier bargaining power to Pharmacovigilance providing companies, and internal rivalry among Pharmacovigilance providers are analysed in Porter's Five Forces analysis to provide the report's readers with a detailed view of the current market dynamics.

This analysis assists report users in evaluating the Pharmacovigilance market based on various parameters such as economies of scale, switching costs, brand loyalty, existing distribution channels, capital investments, manufacturing rights & patents, government regulations, advertising impact, and consumer preference impact. This simplified data is expected to aid the industry's key decision-makers in their decision-making process. Furthermore, this study answers the crucial question of whether or not new entrants should enter the Pharmacovigilance industry.
 
Pharmacovigilance Market Key Trends Analysis

The important factors influencing the growth of the Pharmacovigilance market have been examined in this report. The driving factors that are boosting demand for Pharmacovigilances and the restraining factors that are slowing growth of the Pharmacovigilance industry are addressed in depth, as well as their implications for the worldwide Pharmacovigilance market. In addition, the published analysis identifies and discusses in detail the trends that are driving the market and impacting its growth. In addition, other qualitative variables such as risks connected with operations and key problems faced by market players are covered in the report.

Pharmacovigilance Market Key Segment Analysis

By segmenting the market by product type, application, and geography, the study provides a clear picture of the Pharmacovigilance industry. On the basis of current and future trends, all segments of the Pharmacovigilance industry have been examined. The market and its divisions are forecasted for the years 2021 through 2028. The study identifies the categories that are contributing the most to total market revenue growth, as well as the factors that are supporting their growth.

The research will provide a detailed qualitative and quantitative product type segment analysis for the years 2021 to 2028.

The report study analyses and includes a variety of prospective prospects and aspects affecting various applications.
 
Pharmacovigilance Market Regional Trends and Market Player’s Analysis

North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa are the regions in which the market is divided. In 2020, the worldwide Pharmacovigilance market was dominated by North America. The Asia Pacific region is expected to have the highest CAGR for the Pharmacovigilance market throughout the projected period.


 
The market revenue, market shares, business strategies, recent developments, and growth rates of major players with substantial market shares in the global Pharmacovigilance market are all examined. These firms' recent developments, such as new solution/product launches, research projects, acquisitions, geographic expansions, and technological advancements, are taken into account when determining their position in the Pharmacovigilance market. All important stakeholders in the Pharmacovigilance value chain and technological ecosystem are expected to benefit from the insights offered in the Pharmacovigilance market research study.

In order to provide a broader understanding of the top competitors in the Pharmacovigilance market, the research includes a company market share analysis. Accenture plc, ArisGlobal LLC, BioClinica Inc. (Cinven Partners LLP), Capgemini, Cognizant, International Business Machines Corporation, ICON plc., IQVIA Inc., ITClinical, Parexel International Corporation, Wipro Limited. are among the major participants in the global Pharmacovigilance industry.
 
Scope of the report
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2021
Forecast Period Covered 2021-2028
Units for value Revenue in USD million and CAGR from 2021 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Companies Covered Accenture plc, ArisGlobal LLC, BioClinica Inc. (Cinven Partners LLP), Capgemini, Cognizant, International Business Machines Corporation, ICON plc., IQVIA Inc., ITClinical, Parexel International Corporation, Wipro Limited.
 
Major Highlights of the Pharmacovigilance Market report study:
  • An in-depth examination of the global Pharmacovigilance industry will be published soon.
  • The study examines the global Pharmacovigilance market and offers major actionable information to its players.
  • The research has taken into account all key events in the recent past, providing users with up-to-date industry information.
  • The report study is expected to aid the industry's key decision-makers in their decision-making process.
  • Data on market intelligence, changing market dynamics, existing and predicted market trends, and so on are included in the report.
  • The research includes a detailed examination of the macroeconomic and microeconomic aspects that influence the global Pharmacovigilance industry.
  • The Market Ecosystem and Adoption in Different Markets
  • The global Pharmacovigilance market is being shaped by several major trends.
  • The size of the Pharmacovigilance market in terms of revenue has been measured in the past and will be measured in the future in USD million.
  • Consumer preference patterns and recent industrial developments
  • The worldwide Pharmacovigilance market's competitive landscape and player positioning analysis
  • Major players' key goods and solutions, as well as their business strategies
  • Recommendations for new market entrants as well as existing market participants.
  • The study of niche and potential segments (product type, application, and regions/countries) predicts that promising growth will be noticed.
  • Operating players in the market encounter a number of significant hurdles.
  • An examination of the major risks involved in market operations
 
The report segment of the global Pharmacovigilance market as follows:
Global Pharmacovigilance Market: By Product Type

  • Oncology
  • Neurology
  • Cardiology
  • Respiratory Systems
  • Others

Global Pharmacovigilance Market: By Application
  • Pharmaceuticals Companies
  • Biotechnology Companies
  • Medical Device Companies
  • Others

Global Pharmacovigilance Market: By Region
  • North America
    • U.S.
    • Canada
    • Rest of North America
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China 
    • Japan
    • India
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America
  • Middle East and Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

The report study is drafted to provide actionable insights to the following mentioned audience:
  • Institutes of research and consulting firms
  • Companies are attempting to get into the Pharmacovigilance market.
  • Universities and students
  • Other companies in the Pharmacovigilance market include solution providers, product producers, service providers, and others.
  • Private companies and government agencies that are linked
  • Individuals interested in learning more about the Pharmacovigilance market

Manufacturers and Segments

  • Accenture plc
  • ArisGlobal LLC
  • BioClinica Inc. (Cinven Partners LLP)
  • Capgemini
  • Cognizant
  • International Business Machines Corporation
  • ICON plc.
  • IQVIA Inc.
  • ITClinical
  • Parexel International Corporation
  • Wipro Limited.
  • Oncology
  • Neurology
  • Cardiology
  • Respiratory Systems
  • Others
  • Pharmaceuticals Companies
  • Biotechnology Companies
  • Medical Device Companies
  • Others

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Pharmacovigilance Market Snapshot
          2.1.1. Global Pharmacovigilance Market By Oncology,2019
               2.1.1.1.
               2.1.1.2.Oncology
               2.1.1.3.Neurology
               2.1.1.4.Cardiology
               2.1.1.5.Respiratory Systems
          2.1.2. Global Pharmacovigilance Market By Pharmaceuticals Companies,2019
               2.1.2.1.
               2.1.2.2.Pharmaceuticals Companies
               2.1.2.3.Biotechnology Companies
               2.1.2.4.Medical Device Companies
          2.1.3. Global Pharmacovigilance Market By End-use,2019
          2.1.4. Global Pharmacovigilance Market By Geography,2019

3. Global Pharmacovigilance Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Pharmacovigilance Market Size (US$), By Oncology, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Oncology, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Oncology, 2020
     4.2. Global Pharmacovigilance Market Size (US$), By Oncology, 2018 – 2028

5. Global Pharmacovigilance Market Size (US$), By Pharmaceuticals Companies, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Pharmaceuticals Companies, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Pharmaceuticals Companies, 2020
     5.2. Global Pharmacovigilance Market Size (US$), By Pharmaceuticals Companies, 2018 – 2028

6. Global Pharmacovigilance Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Pharmacovigilance Market Size (US$), By End-use, 2018 – 2028

7. Global Pharmacovigilance Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Pharmacovigilance Market Analysis, 2018 – 2028 
          7.2.1. North America Pharmacovigilance Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Pharmacovigilance Market Size (US$), By Oncology, 2018 – 2028
          7.2.3. North America Pharmacovigilance Market Size (US$), By Pharmaceuticals Companies, 2018 – 2028
          7.2.4. North America Pharmacovigilance Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Pharmacovigilance Market Analysis, 2018 – 2028 
          7.3.1.  Europe Pharmacovigilance Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Pharmacovigilance Market Size (US$), By Oncology, 2018 – 2028
          7.3.3. Europe Pharmacovigilance Market Size (US$), By Pharmaceuticals Companies, 2018 – 2028
          7.3.4. Europe Pharmacovigilance Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Pharmacovigilance Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Pharmacovigilance Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Pharmacovigilance Market Size (US$), By Oncology, 2018 – 2028
          7.4.3. Asia Pacific Pharmacovigilance Market Size (US$), By Pharmaceuticals Companies, 2018 – 2028
          7.4.4. Asia Pacific Pharmacovigilance Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Pharmacovigilance Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Pharmacovigilance Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Pharmacovigilance Market Size (US$), By Oncology, 2018 – 2028
          7.5.3. Latin America Pharmacovigilance Market Size (US$), By Pharmaceuticals Companies, 2018 – 2028
          7.5.4. Latin America Pharmacovigilance Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Pharmacovigilance Market Analysis, 2018 – 2028 
          7.6.1.  MEA Pharmacovigilance Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Pharmacovigilance Market Size (US$), By Oncology, 2018 – 2028
          7.6.3. MEA Pharmacovigilance Market Size (US$), By Pharmaceuticals Companies, 2018 – 2028
          7.6.4. MEA Pharmacovigilance Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Pharmacovigilance Providers
        8.4.1 Accenture plc
                8.4.1.1 Business Description
                8.4.1.2 Accenture plc Geographic Operations
                8.4.1.3 Accenture plc Financial Information
                8.4.1.4 Accenture plc Product Positions/Portfolio
                8.4.1.5 Accenture plc Key Developments
        8.4.2 ArisGlobal LLC
                8.4.2.1 Business Description
                8.4.2.2 ArisGlobal LLC Geographic Operations
                8.4.2.3 ArisGlobal LLC Financial Information
                8.4.2.4 ArisGlobal LLC Product Positions/Portfolio
                8.4.2.5 ArisGlobal LLC Key Developments
        8.4.3 BioClinica Inc. (Cinven Partners LLP)
                8.4.3.1 Business Description
                8.4.3.2 BioClinica Inc. (Cinven Partners LLP) Geographic Operations
                8.4.3.3 BioClinica Inc. (Cinven Partners LLP) Financial Information
                8.4.3.4 BioClinica Inc. (Cinven Partners LLP) Product Positions/Portfolio
                8.4.3.5 BioClinica Inc. (Cinven Partners LLP) Key Developments
        8.4.4 Capgemini
                8.4.4.1 Business Description
                8.4.4.2 Capgemini Geographic Operations
                8.4.4.3 Capgemini Financial Information
                8.4.4.4 Capgemini Product Positions/Portfolio
                8.4.4.5 Capgemini Key Developments
        8.4.5 Cognizant
                8.4.5.1 Business Description
                8.4.5.2 Cognizant Geographic Operations
                8.4.5.3 Cognizant Financial Information
                8.4.5.4 Cognizant Product Positions/Portfolio
                8.4.5.5 Cognizant Key Developments
        8.4.6 International Business Machines Corporation
                8.4.6.1 Business Description
                8.4.6.2 International Business Machines Corporation Geographic Operations
                8.4.6.3 International Business Machines Corporation Financial Information
                8.4.6.4 International Business Machines Corporation Product Positions/Portfolio
                8.4.6.5 International Business Machines Corporation Key Developments
        8.4.7 ICON plc.
                8.4.7.1 Business Description
                8.4.7.2 ICON plc. Geographic Operations
                8.4.7.3 ICON plc. Financial Information
                8.4.7.4 ICON plc. Product Positions/Portfolio
                8.4.7.5 ICON plc. Key Developments
        8.4.8 IQVIA Inc.
                8.4.8.1 Business Description
                8.4.8.2 IQVIA Inc. Geographic Operations
                8.4.8.3 IQVIA Inc. Financial Information
                8.4.8.4 IQVIA Inc. Product Positions/Portfolio
                8.4.8.5 IQVIA Inc. Key Developments
        8.4.9 ITClinical
                8.4.9.1 Business Description
                8.4.9.2 ITClinical Geographic Operations
                8.4.9.3 ITClinical Financial Information
                8.4.9.4 ITClinical Product Positions/Portfolio
                8.4.9.5 ITClinical Key Developments
        8.4.10 Parexel International Corporation
                8.4.10.1 Business Description
                8.4.10.2 Parexel International Corporation Geographic Operations
                8.4.10.3 Parexel International Corporation Financial Information
                8.4.10.4 Parexel International Corporation Product Positions/Portfolio
                8.4.10.5 Parexel International Corporation Key Developments
        8.4.11 Wipro Limited.
                8.4.11.1 Business Description
                8.4.11.2 Wipro Limited. Geographic Operations
                8.4.11.3 Wipro Limited. Financial Information
                8.4.11.4 Wipro Limited. Product Positions/Portfolio
                8.4.11.5 Wipro Limited. Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Pharmacovigilance Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Pharmacovigilance Market Revenue, By Oncology, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Pharmacovigilance Market Revenue, By Pharmaceuticals Companies, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Pharmacovigilance Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Pharmacovigilance Market Revenue, By Oncology, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Pharmacovigilance Market Revenue, By Pharmaceuticals Companies, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Pharmacovigilance Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Pharmacovigilance Market Revenue, By Oncology, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Pharmacovigilance Market Revenue, By Pharmaceuticals Companies, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Pharmacovigilance Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Pharmacovigilance Market Revenue, By Oncology, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Pharmacovigilance Market Revenue, By Pharmaceuticals Companies, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Pharmacovigilance Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Pharmacovigilance Market Revenue, By Oncology, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Pharmacovigilance Market Revenue, By Pharmaceuticals Companies, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Pharmacovigilance Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Pharmacovigilance: Market Segmentation 
FIG. 2 Global Pharmacovigilance Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Pharmacovigilance Market, By Oncology, 2019 (US$ Mn) 
FIG. 5 Global Pharmacovigilance Market, By Pharmaceuticals Companies, 2019 (US$ Mn) 
FIG. 6 Global Pharmacovigilance Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Pharmacovigilance Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Pharmacovigilance Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Pharmacovigilance Providers, 2019
FIG. 11 Global Pharmacovigilance Market Revenue Contribution, By Oncology, 2019 & 2028 (Value %) 
FIG. 12 Global Pharmacovigilance Market Revenue Contribution, By Pharmaceuticals Companies, 2019 & 2028 (Value %) 
FIG. 13 Global Pharmacovigilance Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Pharmacovigilance Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Pharmacovigilance Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Pharmacovigilance Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Pharmacovigilance Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Pharmacovigilance Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Pharmacovigilance market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Pharmacovigilance Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Pharmacovigilance Market Value, By Segment1, 2018 – 2028
TABLE  North America Pharmacovigilance Market Value, By Segment2, 2018 – 2028
TABLE  North America Pharmacovigilance Market Value, By Country, 2018 – 2028
TABLE  Europe Pharmacovigilance Market Value, By Segment1, 2018 – 2028
TABLE  Europe Pharmacovigilance Market Value, By Segment2, 2018 – 2028
TABLE  Europe Pharmacovigilance Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Pharmacovigilance Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Pharmacovigilance Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Pharmacovigilance Market Value, By Country, 2018 – 2028
TABLE  Latin America Pharmacovigilance Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Pharmacovigilance Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Pharmacovigilance Market Value, By Country, 2018 – 2028
TABLE  MEA Pharmacovigilance Market Value, By Segment1, 2018 – 2028
TABLE  MEA Pharmacovigilance Market Value, By Segment2, 2018 – 2028
TABLE  MEA Pharmacovigilance Market Value, By Country, 2018 – 2028
TABLE  Accenture plc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  ArisGlobal LLC: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  BioClinica Inc. (Cinven Partners LLP): Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Capgemini: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Cognizant: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  International Business Machines Corporation: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  ICON plc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  IQVIA Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  ITClinical: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Parexel International Corporation: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Wipro Limited.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Pharmacovigilance Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Pharmacovigilance Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Pharmacovigilance Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Pharmacovigilance Market, By Geography, 2019 (US$ Mn)
FIG.  Global Pharmacovigilance Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Pharmacovigilance Providers, 2016
FIG.  Global Pharmacovigilance Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Oncology Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Neurology Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Cardiology Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Respiratory Systems Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Pharmacovigilance Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Pharmaceuticals Companies Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Biotechnology Companies Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Medical Device Companies Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Pharmacovigilance Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Pharmacovigilance Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Pharmacovigilance Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Pharmacovigilance Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Pharmacovigilance Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Pharmacovigilance Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Pharmacovigilance Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Pharmacovigilance Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Pharmacovigilance Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Pharmacovigilance Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Pharmacovigilance Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Pharmacovigilance Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Pharmacovigilance Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Pharmacovigilance Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Pharmacovigilance Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Pharmacovigilance Market Value, 2018 – 2028, (US$ Mn)